Canadian Online Pharmacy

CDER New June 25, 2012

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

June 22, 2012


New and Generic Drug Approvals

June 21, 2012

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Acetylcysteine acetylcysteine Solution; Oral Innopharma Inc Approval
Jakafi ruxolitinib phosphate Tablet; Oral Incyte Corp Labeling Revision
Noxafil posaconazole Suspension; Oral Schering Labeling Revision
Noxafil posaconazole Suspension; Oral Schering Labeling Revision
Raloxifene Hydrochloride raloxifene hydrochloride Tablet; Oral Invagen Pharms Tentative Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery